深圳立健药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
53
NMPA:53
Drug Approvals
Daptomycin for Injection
- Product Name
- 注射用达托霉素
- Approval Number
- 国药准字H20243324
- Approval Date
- Mar 12, 2024
NMPA
Cefazolin Sodium for Injection
- Product Name
- 注射用头孢唑林钠
- Approval Number
- 国药准字H20143066
- Approval Date
- Nov 27, 2023
NMPA
Cefazolin Sodium for Injection
- Product Name
- 注射用头孢唑林钠
- Approval Number
- 国药准字H20143067
- Approval Date
- Nov 27, 2023
NMPA
Cefprozil for Suspension
- Product Name
- 头孢丙烯干混悬剂
- Approval Number
- 国药准字H20234253
- Approval Date
- Sep 28, 2023
NMPA
Ceftezole Sodium for Injection
- Product Name
- 注射用头孢替唑钠
- Approval Number
- 国药准字H20084563
- Approval Date
- Jul 7, 2023
NMPA
Ceftezole Sodium for Injection
- Product Name
- 注射用头孢替唑钠
- Approval Number
- 国药准字H20084159
- Approval Date
- Jun 14, 2023
NMPA
Ceftezole Sodium for Injection
- Product Name
- 注射用头孢替唑钠
- Approval Number
- 国药准字H20084158
- Approval Date
- Jun 14, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
Clinical Trials
No trials found
News
No news found